Compounds > 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Graft Occlusion, Vascular

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Graft Occlusion, Vascular in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakao, A1
Huang, CS1
Stolz, DB1
Wang, Y1
Franks, JM1
Tochigi, N1
Billiar, TR1
Toyoda, Y1
Tzeng, E1
McCurry, KR1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Graft Occlusion, Vascular

ArticleYear
Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.
    Cardiovascular research, 2011, Feb-01, Volume: 89, Issue:2

    Topics: Animals; Aorta, Abdominal; Apoptosis; Carbon Monoxide; Endothelial Cells; Graft Occlusion, Vascular;

2011